Showing 1 - 10 of 43
This paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade...
Persistent link: https://www.econbiz.de/10010712160
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
Interactive learning, particularly between firms and public research organizations (PRO), nurtures the dynamics of systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by developing countries. But why this is so? Based on...
Persistent link: https://www.econbiz.de/10010712332
to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility …
Persistent link: https://www.econbiz.de/10010856422
. However, over fifty years, India has had much more success in building indigenous capabilities in pharmaceuticals than Brazil …Since the mid-twentieth century, the national objective of India and Brazil has been to develop industrial capabilities … in essential sectors such as pharmaceuticals. At the outset, they shared some common features: a considerable period of …
Persistent link: https://www.econbiz.de/10010712130
The impact of patent protection on biomedical innovation has been a controversial issue. Although a “medical anti-commons” has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys...
Persistent link: https://www.econbiz.de/10010712400
of the effects of NTMs on Indian pharmaceutical exports (bulk drugs and formulations). Within the broad context of India … explaining India's relatively poor export performance …
Persistent link: https://www.econbiz.de/10010712394
, several countries like India, which played an important role as producers and exporters of generic copies of brand name …
Persistent link: https://www.econbiz.de/10010856343
The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti-commons" has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys that...
Persistent link: https://www.econbiz.de/10010712264
The mixed picture of extant research on the relationship between internal and external R&D prompts us to ask such a question: under what conditions is there complementarity or substitutability between different R&D strategies? The goal of this paper is to contribute to the empirical literature...
Persistent link: https://www.econbiz.de/10010712267